Individual case reports describe changes in melanocytic naevi and melanoma diagnoses in people reported to have used melanotan products; case reports do not establish causality.
Hjuler & Lorentzen, 2014 · PubMed · Schulze et al., 2014 · PubMed
An individual case report describes priapism in temporal association with melanotan II; the report does not establish causality.
Image 01 / 01Research compound
Melanotan II
Cyclic α-MSH analogue — melanocortin agonist
Research compoundCA$105.00
Melanotan II/
CA$105.00
Documented harms
View evidenceIndividual case reports describe changes in melanocytic naevi and melanoma diagnoses in people reported to have used melanotan products; case reports do not establish causality.
Hjuler & Lorentzen, 2014 · PubMed · Schulze et al., 2014 · PubMed
An individual case report describes priapism in temporal association with melanotan II; the report does not establish causality.
How it works
Early human observation reported melanotan II pharmacology in fewer than three volunteers.
Where the evidence comes from
View evidenceMelanotan II findings shown here come from individual case reports and an early human observation.
Hjuler & Lorentzen, 2014 · PubMed · Schulze et al., 2014 · PubMed · Mallory et al., 2021 · PubMed · Dorr et al., 1996 · PubMed
What's still open
Melanotan II case reports shown here do not establish causality.
Hjuler & Lorentzen, 2014 · PubMed · Schulze et al., 2014 · PubMed · Mallory et al., 2021 · PubMed
